| Tempus Priority Study: A Pan-tumor Observational Study (NCT05179824) | Tempus AI | 2020-10-19 |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (NCT03896958) | SpeciCare | 2019-03-21 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer (NCT03775525) | Genzada Pharmaceuticals USA, Inc. | 2019-03-01 |
| Nordic Gastric and Esophageal Tumor Study (NCT05688761) | Karolinska Institutet | 2019-01-01 |
| Early Support in Primary Care for People Starting Treatment for Cancer (NCT03719716) | NHS Lothian | 2019-01-01 |
| Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy (NCT04032353) | Yanqing Li | 2018-12-31 |
| Audit of the Spanish EURECCA Esophagogastric Cancer Registry (NCT03541629) | Parc de Salut Mar | 2018-07-26 |
| Investigation of an Abdominal Compression Device (NCT04270890) | The Clatterbridge Cancer Centre NHS Foundation Trust | 2018-06-21 |
| Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers (NCT03468712) | West China Hospital | 2018-03-31 |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry (NCT03452774) | Massive Bio, Inc. | 2018-01-01 |
| Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer (NCT03347162) | Rigshospitalet, Denmark | 2017-12-01 |
| A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors (NCT03129139) | Minneamrita Therapeutics LLC | 2017-10-10 |
| Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) (NCT03133286) | DxTerity Diagnostics | 2017-04-06 |
| Genomic Testing and Resulting Medical Decisions (NCT03301493) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2017-03-30 |
| Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy (NCT03082833) | Samsung Medical Center | 2017-02-01 |
| Real-time Activity Monitoring to Prevent Admissions During RadioTherapy (NCT03102229) | Montefiore Medical Center | 2016-07-01 |
| Maintenance Treatment With S-1 in Gastric Cancer Patients (NCT03701373) | Sun Yat-sen University | 2016-01-01 |
| GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer (NCT05088304) | Jinling Hospital, China | 2015-09-01 |
| NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma (NCT02486601) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2015-06-01 |
| A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 (NCT01614522) | ASLAN Pharmaceuticals | 2012-03-01 |
| Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial (NCT00165048) | Chinese University of Hong Kong | 2004-10-01 |
| Role of Routine Nasogastric Decompression After Subtotal Gastrectomy (NCT00164918) | Chinese University of Hong Kong | 2004-09-01 |
| Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction (NCT00080002) | Enzon Pharmaceuticals, Inc. | 2003-12-01 |
| Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer (NCT00201747) | Ohio State University Comprehensive Cancer Center | 2001-09-01 |